Literature DB >> 6288701

The binding of fibrinogen to its platelet receptor.

G A Marguerie, N Ardaillou, G Cherel, E F Plow.   

Abstract

Specific receptors for fibrinogen can be induced on platelets by a variety of stimuli. In this study, two independent approaches have implicated the D domain of fibrinogen in its interaction with the platelet. Immunochemically purified Fab fragments of anti-fibrinogen and anti-D inhibited 125I-fibrinogen binding to platelets in a dose-dependent fashion and platelet aggregation. In contrast, Fab fragments of anti-E produced only a slight inhibition of fibrinogen binding and nonimmune Fab fragments had no effect. Fibrinogen was digested with plasmin in the presence of 5 mM calcium and fragment D and E of Mr 100,000 and 50,000, respectively, were isolated. This D fragment inhibited 125I-fibrinogen binding to platelets in a concentration-dependent fashion, whereas the E fragment was ineffective. With 125I-fibrinogen at 0.17 microM, nonlabeled fibrinogen inhibited binding by 50% at 0.7 microM, whereas 170 microM fragment D was required to produce 50% inhibition. D fragment of Mr 80,000, generated in the absence of calcium, was noninhibitory. These observations provide strong evidence for the participation of the D domain in the binding of fibrinogen by its platelet receptor and suggest that the recognition site is lost in the conversion of the Mr 100,000 to 80,000 D species.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6288701

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Partial mRNA sequences for human A alpha, B beta, and gamma fibrinogen chains: evolutionary and functional implications.

Authors:  J A Kant; S T Lord; G R Crabtree
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

2.  Modulation of polymorphonuclear leukocyte microbicidal activity and oxidative metabolism by fibrinogen degradation products D and E.

Authors:  J W Kazura; J D Wenger; R A Salata; A Z Budzynski; G H Goldsmith
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

Review 3.  Current issues in thrombosis prevention with antiplatelet drugs.

Authors:  G de Gaetano; C Cerletti; E Dejana; J Vermylen
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

4.  Retention of the glycoprotein IIb-IIIa complex in the isolated platelet cytoskeleton. Effects of separable assembly of platelet pseudopodal and contractile cytoskeletons.

Authors:  M E Wheeler; A C Cox; R C Carroll
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

5.  Polyethylene glycol-grafted bovine pericardium: a novel hybrid tissue resistant to calcification.

Authors:  S C Vasudev; T Chandy
Journal:  J Mater Sci Mater Med       Date:  1999-02       Impact factor: 3.896

6.  Role of thrombospondin in platelet aggregation.

Authors:  L L Leung
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

7.  Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding.

Authors:  E Dejana; L R Languino; N Polentarutti; G Balconi; J J Ryckewaert; M J Larrieu; M B Donati; A Mantovani; G Marguerie
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

8.  Von Willebrand factor promotes endothelial cell adhesion via an Arg-Gly-Asp-dependent mechanism.

Authors:  E Dejana; M G Lampugnani; M Giorgi; M Gaboli; A B Federici; Z M Ruggeri; P C Marchisio
Journal:  J Cell Biol       Date:  1989-07       Impact factor: 10.539

9.  Fibrinogen induces adhesion, spreading, and microfilament organization of human endothelial cells in vitro.

Authors:  E Dejana; S Colella; L R Languino; G Balconi; G C Corbascio; P C Marchisio
Journal:  J Cell Biol       Date:  1987-05       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.